Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2018-10-08
2023-01-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
At first we will investigate to what extent motor delay, reduced force, higher BMI, behavioral, ADL and participation problems occur in toddlerhood in DCD children and how this relates to TD children. We will also look into the evolution of these parameters in time (stability of development).
Secondly we will explore if the diagnosis of DCD can be predicted using a standardized test before the age of five.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Development and Diagnostic Trajectories in DCD
NCT05617586
An Explorative RVA of the Motor Development of Children With DCD <2y
NCT04126395
Rhythmic Interlimb Coordination in Children with Developmental Coordination Disorder
NCT04891562
Developmental Coordination Disorder
NCT05154799
Premie DCD Imaging Intervention Study
NCT04483401
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Assessment scores (AIMS or/and BSID) before the age of three will be retrieved retrospectively in the clinical group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DCD Group
Children diagnosed with DCD or at-risk DCD at two or three years of age
Test Battery
All toddlers (DCD children + TD children) included in the study will be tested at three points in time, that is at the age of 3y, 4y and 5y with an extensive test battery. Questionnaires will be filled in by parents and teachers. Children will be tested using different instruments.
Control Group
Typically developing children
Test Battery
All toddlers (DCD children + TD children) included in the study will be tested at three points in time, that is at the age of 3y, 4y and 5y with an extensive test battery. Questionnaires will be filled in by parents and teachers. Children will be tested using different instruments.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Test Battery
All toddlers (DCD children + TD children) included in the study will be tested at three points in time, that is at the age of 3y, 4y and 5y with an extensive test battery. Questionnaires will be filled in by parents and teachers. Children will be tested using different instruments.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. At least one parent speaks Dutch to the child
1. The child is three years of age at the moment of the first testing
2. Little-DCD-Q score ≥ 55 at 3y
3. M-ABC-2 percentilescore ≥25 at 3y
4. No medical diagnoses possibly influencing the motor development (DCD, ADHD, ASS, CP,…)
5. No history of developmental motor stimulation (therapy) and/or support
6. Gestational age ≥37w
7. Birthweight ≥2500g
8. At least one parent speaks Dutch to the child
3 Years
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amy Roubaix
Role: PRINCIPAL_INVESTIGATOR
University Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ghent University
Ghent, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B670201837290
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.